Revelation Biosciences Inc
General ticker "REVB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.4M
Revelation Biosciences Inc does not follow the US Stock Market performance with the rate: -35.6%.
Estimated limits based on current volatility of 3.3%: low 0.31$, high 0.33$
Factors to consider:
- Current price 95.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.15$, 27.68$]
- 2024-12-30 to 2025-12-30 estimated range: [3.52$, 13.59$]
Financial Metrics affecting the REVB estimates:
- Negative: Non-GAAP EPS, $ of -43.47 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -63.93 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
Short-term REVB quotes
Long-term REVB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $11.95MM | $10.86MM | $8.66MM |
| Operating Income | $-11.95MM | $-10.86MM | $-8.66MM |
| Non-Operating Income | $-0.04MM | $0.03MM | $8.54MM |
| R&D Expense | $6.91MM | $5.38MM | $4.15MM |
| Income(Loss) | $-11.99MM | $-10.83MM | $-0.12MM |
| Profit(Loss) | $-11.99MM | $-10.83MM | $-0.12MM |
| Stockholders Equity | $-0.10MM | $1.05MM | $6.65MM |
| Assets | $2.04MM | $5.50MM | $12.21MM |
| Operating Cash Flow | $-11.09MM | $-11.22MM | $-7.29MM |
| Capital expenditure | $0.13MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.13MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $8.00MM | $15.20MM | $14.03MM |
| Earnings Per Share* | $-1,275.02 | $-600.77 | $-0.53 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.